Wow, the NAOS Emerging Companies Long / Short Equity Fund had a doozy of a month in May, down 11.5% versus benchmark (Small Ordinaries Accumulation Index) down 1.89%. Need to live with that kind of volatility to achieve 21.61% per annum returns since inception.
"A positive performer was Phylogica Limited (PYC), a peptide drug discovery technology with multiple partnership agreements in place with large pharmaceutical companies."
"The fund maintained its overweight exposure to the healthcare sector with many upcoming catalysts for positions within the portfolio."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
-0.045(3.13%) |
Mkt cap ! $813.6M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.46 | $1.36 | $314.1K | 222.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 330 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 12708 | 2 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |